GSK Receives “Complete Response” Letter For Cervarix BLA
Drug maker will respond to FDA “as soon as possible” to answer outstanding questions related to the HPV vaccine.
Drug maker will respond to FDA “as soon as possible” to answer outstanding questions related to the HPV vaccine.